Skip to main content
Fig. 2 | BMC Urology

Fig. 2

From: Population-based study of long-term anticoagulation for treatment and secondary prophylaxis of venous thromboembolism in men with prostate cancer in Sweden

Fig. 2

Type of anticoagulant(s) prescribed during the 4 weeks after the index VTE among the 1413 men with prostate cancer and VTE (2013–2017) stratified by type of VTE (DVT/PE). Note: Men were eligible to have received more than one type of anticoagulant treatment during this 4-week time period. In total, an outpatient prescription for an anticoagulant during the 4 weeks after the index VTE was issued to 95.5% of men, with 4.5% of me issued an anticoagulant prescription after 4 weeks. DOAC, direct oral anticoagulant; DVT, deep vein thrombosis; PE, pulmonary embolism; VKA, vitamin K antagonist; VTE, venous thromboembolism

Back to article page

BMC Urology

ISSN: 1471-2490

Contact us